Longitudinal follow-up of the IPSS within the 5 years following treatment of a localized prostate cancer: overall analysis and by type of treatment

Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
R LorionJ Irani

Abstract

The International Prostate Score Symptom (IPSS) and the question of quality of life (QOL-Q) associated were used in this study for monitoring patients treated for localized prostate cancer (P-Ca). Three groups treated with radical prostatectomy (RP), external beam radiotherapy (RT) or brachytherapy (BRACHY) completed the self-administered questionnaire IPSS and Q-QOL before treatment (bef-TT), after 3 months and once a year for 5 years. The study included 40 PR, 40 RT and 40 BRACHY. There was no difference between the three groups in bef-TT for the IPSS and Q-QOL or in the patients' characteristics, and P-Ca except for age and a higher PSA in the RT group (70.6 years old and 10.0 ng/mL vs. 66.5/66.2 and 7.1/6.2 for RP and CURIE respectively). The impact, no matter what treatment they received, was significant after the third month and then went back to the pre-AN1 at TT. The analysis by group treatment showed no significant difference between groups at 3months and during the first 4 years of follow-up. In the fifth year the RT group had a greater IPSS than BRACHY and PR groups (P<0.04). This study showed no degradation of the IPSS or Q-QOL remote treatment of localized prostate cancer. Urinary incontinence has been partially ex...Continue Reading

References

Nov 3, 2004·International Journal of Radiation Oncology, Biology, Physics·Véronique BeckendorfPierre Bey
Feb 13, 2007·International Journal of Radiation Oncology, Biology, Physics·Catherine BuronAlain Livartowski
Mar 21, 2008·The New England Journal of Medicine·Martin G SandaJohn T Wei
Sep 2, 2008·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·P PerrinA Ruffion
Apr 13, 2010·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·O SimoninG Karsenty
Nov 9, 2010·European Urology·Axel HeidenreichUNKNOWN European Association of Urology
Dec 7, 2010·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·L SalomonUNKNOWN Oncology Committee of the French Association of Urology (CCAFU)
Oct 30, 2012·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·A ErausoG Fournier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.